Pharma companies inch forward in integrating access to medicine into business practices

Pharmaceutical companies continue to inch forward when it comes to embedding access to medicine into business practices in low- and middle-income countries. There are signs of progress in how they are integrating access to medicine into governance structures, R&D processes and monitoring efforts. Yet efforts to address access to specific products still remain focused on a few countries.

Explore further

Get in touch

Back to top |